Enhancement of Radiotherapy with Human Mesenchymal Stem Cells Containing Gold Nanoparticles
- PMID: 33364427
- PMCID: PMC7744188
- DOI: 10.18383/j.tom.2020.00026
Enhancement of Radiotherapy with Human Mesenchymal Stem Cells Containing Gold Nanoparticles
Abstract
Radiotherapy is a common approach for the treatment of a wide variety of cancer types. Available data indicate that nanoparticles can enhance the effect of radiotherapy. We report the use of human mesenchymal stem cells to selectively deliver gold nanoparticles (GNPs) to MDA-MB-231 breast tumor xenografts in mice for the purpose of enhancing the effect of radiation therapy. Targeted delivery of GNPs to the tumor site, followed by irradiation of the tumor, enabled control of tumor growth. The results indicate that tumor-selective GNP delivery by human mesenchymal stem cells may represent a viable way to enhance the effectiveness of radiotherapy.
Keywords: MSCs; breast cancer; molecular imaging; nanomedicine; targeted delivery; tumor microenvironment.
© 2020 The Authors. Published by Grapho Publications, LLC.
Figures
Similar articles
-
Targeted dose enhancement in radiotherapy for breast cancer using gold nanoparticles, part 2: A treatment planning study.Med Phys. 2017 May;44(5):1993-2001. doi: 10.1002/mp.12178. Epub 2017 Apr 17. Med Phys. 2017. PMID: 28236658
-
Targeted dose enhancement in radiotherapy for breast cancer using gold nanoparticles, part 1: A radiobiological model study.Med Phys. 2017 May;44(5):1983-1992. doi: 10.1002/mp.12180. Epub 2017 Mar 28. Med Phys. 2017. PMID: 28236655
-
Enhancing the effect of 4MeV electron beam using gold nanoparticles in breast cancer cells.Phys Med. 2017 Mar;35:18-24. doi: 10.1016/j.ejmp.2017.02.014. Epub 2017 Mar 9. Phys Med. 2017. PMID: 28285936
-
Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.Int J Nanomedicine. 2020 Nov 24;15:9407-9430. doi: 10.2147/IJN.S272902. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33262595 Free PMC article. Review.
-
Polymer decorated gold nanoparticles in nanomedicine conjugates.Adv Colloid Interface Sci. 2017 Nov;249:386-399. doi: 10.1016/j.cis.2017.01.007. Epub 2017 Feb 15. Adv Colloid Interface Sci. 2017. PMID: 28259207 Review.
Cited by
-
Research progress on factors affecting the sensitivity of breast cancer to radiotherapy: a narrative review.Transl Cancer Res. 2024 Jul 31;13(7):3869-3888. doi: 10.21037/tcr-24-71. Epub 2024 Jul 16. Transl Cancer Res. 2024. PMID: 39145054 Free PMC article. Review.
-
[18F]FDG-labelled stem cell PET imaging in different route of administrations and multiple animal species.Sci Rep. 2021 May 25;11(1):10896. doi: 10.1038/s41598-021-90383-4. Sci Rep. 2021. PMID: 34035416 Free PMC article.
-
Functionalized Hybrid Iron Oxide-Gold Nanoparticles Targeting Membrane Hsp70 Radiosensitize Triple-Negative Breast Cancer Cells by ROS-Mediated Apoptosis.Cancers (Basel). 2023 Feb 11;15(4):1167. doi: 10.3390/cancers15041167. Cancers (Basel). 2023. PMID: 36831510 Free PMC article.
-
Tumor-tropic Trojan horses: Using mesenchymal stem cells as cellular nanotheranostics.Theranostics. 2024 Jan 1;14(2):571-591. doi: 10.7150/thno.90187. eCollection 2024. Theranostics. 2024. PMID: 38169524 Free PMC article. Review.
-
A Promising, Novel Radiosensitizer Nanodrug Complex for Oral Cavity Cancer: Cetuximab and Cisplatin-Conjugated Gold Nanoparticles.Balkan Med J. 2021 Sep;38(5):278-286. doi: 10.5152/balkanmedj.2021.21013. Balkan Med J. 2021. PMID: 34462254 Free PMC article.
References
-
- Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 2005;104:1129–1137. - PubMed
-
- Wardman P. Chemical radiosensitizers for use in radiotherapy. Clin Oncol (R Coll Radiol). 2007;19:397–417. - PubMed
-
- Naylor MA, Thomson P. Recent advances in bioreductive drug targeting. Mini Rev Med Chem. 2001;1:17–29. - PubMed
-
- Wardman P. Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia. Curr Med Chem. 2001;8:739–761. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous